Kihealth Inc., a precision diagnostics company advancing early disease detection, has announced the successful close of its $5 million oversubscribed seed round, signaling strong investor confidence in its pioneering approach to metabolic health and chronic disease prevention. The funding will…
Ribbon Bio and Scala Biodesign—two innovative biotechnology companies led by dynamic women CEOs—have announced a new partnership focused on enhancing the performance and accessibility of enzyme-driven DNA synthesis. This collaboration brings together cutting-edge technologies and complementary scientific expertise to address…
Trinity Life Sciences, a recognized leader in commercialization for the life sciences sector, has officially announced a transformative rebranding initiative that signals a new era for the organization. With a bold, forward-looking identity and enhanced AI-powered solutions, the company is…
A new preclinical study titled “Intravitreal Transplantation of Retinal Progenitor Cells Improves Outcome Measures in a Rat Model of Diabetic Retinopathy” provides compelling evidence that retinal progenitor cell (RPC) transplantation may protect and restore retinal function in diabetic retinopathy (DR),…
CTMC, a joint venture between Resilience and The University of Texas MD Anderson Cancer Center, has announced a strategic collaboration with Einstein Hospital Israelita in São Paulo, Brazil, to accelerate the development, manufacturing, and adoption of advanced cell therapies across…
Neuraptive Therapeutics, Inc., a biotechnology company developing novel therapies to improve outcomes for patients with peripheral nerve injuries (PNI), announced the enrollment of the first patient in its pivotal Phase 3 clinical trial evaluating NTX-001, a novel therapeutic designed to…
iECURE, Inc., a clinical-stage genome editing company pioneering variant-agnostic in vivo targeted gene insertion therapies for severe liver disorders, announced that new data from the ongoing OTC-HOPE clinical trial evaluating its lead candidate ECUR-506 will be presented at two of…
SOTIO Biotech, a clinical-stage biopharmaceutical company owned by PPF Group, announced two key executive appointments aimed at accelerating the development of its growing pipeline of novel antibody-drug conjugates (ADCs) and immunotherapies designed to treat difficult-to-manage solid tumors. The company has…
BioIVT, a global leader in biospecimen solutions and research support for drug and diagnostic development, announced that it will feature its expansive portfolio of cellular solutions at several major cell and gene therapy (CGT) conferences this fall. Among these, the…
Revvity, Inc. announced a major expansion of its Type 1 diabetes (T1D) diagnostics portfolio through the development of a population-scale early detection assay, supported by Sanofi (EURONEXT: SAN and NASDAQ: SNY). The initiative aims to revolutionize how T1D is identified…